MyoPax at bio:cap Europe 2026

We had a fantastic time at bio:cap Europe 2026, the International Life Science & AI Investival held June 9–11 in Berlin. Our booth served as a hub for engaging discussions with potential investors and for building exciting new relationships with future partners and collaborators.

Our CEO, Verena Schoewel-Wolf, took to the startup stage to pitch MyoPax and joined an insightful panel discussion on the topic of „Europe has the science – where is the money?“.

Events like bio:cap are exactly where we want to be as we advance our cell and gene therapy programmes. Thank you to everyone who stopped by! We look forward to continuing the conversation!